Sexual Wellness & Intimacy Support Peptide
PT-141 (Bremelanotide), also known as Bremelanotide, is a synthetic peptide originally developed from the melanocortin family. Unlike traditional sexual enhancement therapies that act on the vascular system, PT-141 works directly on the central nervous system, stimulating the brain pathways that regulate arousal, desire, and intimacy.
This makes PT-141 effective for both men and women, enhancing libido, improving sexual satisfaction, and addressing performance issues related to low sexual desire.
Key Benefits
- Increases Sexual Desire & Arousal – Enhances libido in both men and women.
- Supports Erectile Function – Improves sexual performance without relying solely on blood flow.
- Enhances Intimacy & Confidence – Reduces performance anxiety and improves satisfaction.
- Acts on Brain Pathways – Works through central arousal mechanisms, not just vascular effects.
- Effective for Both Genders – Supports sexual wellness in men and women.
- Non-Habit Forming – Does not carry the dependency risks of some pharmaceutical alternatives.
Who Can Benefit
- Men experiencing erectile dysfunction (ED) or low libido
- Women with hypoactive sexual desire disorder (HSDD)
- Couples seeking enhanced intimacy and connection
- Adults pursuing sexual wellness as part of longevity or regenerative programs
Recommended Dosage By Doctor
Administration: 20 I.U 5 days onn 2 days off
Cycle Duration: 12 Weeks
Best Time: Morning Before Breakfast
⚠️DISCLAIMER
Syncom products are intended for professional use only and must be administered under the strict supervision of a licensed healthcare professional.
Our formulations and sterile solutions are not intended for self-administration and are not a replacement for prescribed medical treatments. Always consult a qualified healthcare provider before initiating peptide therapy to ensure safe and appropriate use.
Syncom assumes no liability for misuse, unsupervised application, or use outside professional settings.